10606111000001100: Clairette 2000/35 tablets (Kent Pharma (UK) Ltd) (product)

• SNOMED CT Concept\Pharmaceutical / biologic product\...
• \UK product\Actual medicinal product\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \UK product\Virtual medicinal product\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \UK product\Virtual therapeutic moiety\Co-cyprindiol\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \UK product\Trade family\Clairette\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Co-cyprindiol\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing cyproterone\Product containing cyproterone and ethinylestradiol\Product containing only cyproterone and ethinylestradiol (medicinal product)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing cyproterone\Product containing cyproterone and ethinylestradiol\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing cyproterone\Product containing cyproterone in oral dose form (medicinal product form)\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing cyproterone\Product containing cyproterone and ethinylestradiol\Product containing only cyproterone and ethinylestradiol (medicinal product)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing cyproterone\Product containing cyproterone and ethinylestradiol\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing cyproterone\Product containing cyproterone in oral dose form (medicinal product form)\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing estrogen receptor agonist (product)\Product containing ethinylestradiol\Product containing ethinylestradiol in oral dose form (medicinal product form)\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing estrogen receptor agonist (product)\Product containing ethinylestradiol\Product containing cyproterone and ethinylestradiol\Product containing only cyproterone and ethinylestradiol (medicinal product)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing estrogen receptor agonist (product)\Product containing ethinylestradiol\Product containing cyproterone and ethinylestradiol\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing pregnane\Product containing cyproterone\Product containing cyproterone and ethinylestradiol\Product containing only cyproterone and ethinylestradiol (medicinal product)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing pregnane\Product containing cyproterone\Product containing cyproterone and ethinylestradiol\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing pregnane\Product containing cyproterone\Product containing cyproterone in oral dose form (medicinal product form)\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing ethinylestradiol\Product containing ethinylestradiol in oral dose form (medicinal product form)\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing ethinylestradiol\Product containing cyproterone and ethinylestradiol\Product containing only cyproterone and ethinylestradiol (medicinal product)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing ethinylestradiol\Product containing cyproterone and ethinylestradiol\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiacne agent (product)\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as contraceptive (product)\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \Medicinal product\Product manufactured as oral dose form\Product containing ethinylestradiol in oral dose form (medicinal product form)\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)
• \Medicinal product\Product manufactured as oral dose form\Product containing cyproterone in oral dose form (medicinal product form)\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet\Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
2877521000001112	Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
2877541000001119	Clairette 2000/35 tablets (Kent Pharma (UK) Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module

Expanded Value Set

This concept is not in any reference sets

Back to Start